VERGA, LUISA

VERGA, LUISA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.009 secondi).
Titolo Tipologia Data di pubblicazione Autori File
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) 01 - Articolo su rivista 2011 VERGA, LUISAPOGLIANI, ENRICO MARIA +
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 02 - Intervento a convegno 2017 Farina, FCeccon, MMori, SVerga, LBorin, LMMologni, LFontana, DGEETA, GEETAPiazza, RGambacorti-Passerini, C
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 01 - Articolo su rivista 2020 Bossi E.Aroldi A.Steidl C.Verga L.Fontana D.Sharma G. G.Mologni L.Piazza R.Gambacorti Passerini C. +
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 01 - Articolo su rivista 2021 Vergnano, BeatriceCalcinati, SerenaSignori, DavideBenini, AnnalisaPozzi, Maria RosaVerga, LuisaPizzagalli, JonataBonfanti, PaoloBellani, GiacomoFoti, Giuseppe
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 01 - Articolo su rivista 2021 Coppadoro, AndreaBenini, AnnalisaFruscio, RobertVerga, LuisaMazzola, PaoloBellelli, GiuseppeCarbone, MarcoSoria, AlessandroIppolito, DavideCiterio, GiuseppeValsecchi, Maria GraziaBiondi, AndreaPesci, AlbertoBonfanti, PaoloGaudesi, DavideBellani, GiacomoFoti, Giuseppe +
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 01 - Articolo su rivista 2022 Bossi, ElisaAroldi, AndreaBorin, Lorenza MariaVerga, LuisaFontana, DilettaCocito, FedericaManghisi, BeatriceRindone, GiovanniCavalca, FabrizioRipamonti, AlessiaAntolini, LauraPiazza, Rocco GiovanniGambacorti-Passerini, Carlo +
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 01 - Articolo su rivista 2023 Rindone, GiovanniAroldi, AndreaBossi, ElisaVerga, LuisaZambrotta, GiovanniTarantino, SaraPiazza, RoccoGambacorti-Passerini, Carlo +